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The pharmacology of hSK1, a small conductance calcium-activated potassium channel, was studied
in mammalian cell lines (HEK293 and COS-7). In these cell types, hSK1 forms an apamin-sensitive
channel with an IC50 for apamin of 8 nM in HEK293 cells and 12 nM in COS-7 cells. The currents in
HEK293 cells were also sensitive to tubocurarine (IC50=23 mM), dequalinium (IC50=0.4 mM), and
the novel dequalinium analogue, UCL1848 (IC50=1 nM). These results are very dierent from the
pharmacology of hSK1 channels expressed in Xenopus oocytes and suggest the properties of the
channel may depend on the expression system. Our ®ndings also raise questions about the role of
SK1 channels in generating the apamin-insensitive slow afterhyperpolarization observed in central
neurones.
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Introduction Small conductance calcium-activated potassium
channels (SK channels) are thought to underlie the slow
afterhyperpolarizations (AHP) that follow action potentials in
many neurones (for reviews see Sah, 1996; Vergara et al.,
1998). They are also found in many non-excitable cells.
Subtypes of the SK channel have been postulated on the basis
of pharmacological and biochemical evidence (Wadsworth et
al., 1994; Dunn et al., 1996). A molecular basis for their
diversity has recently been provided by the identi®cation of
three genes (SK1-3) coding for similar small conductance
calcium-activated potassium channels (Kohler et al., 1996)
which can form homo- or heteromeric channels when
expressed in Xenopus oocytes (Ishii et al., 1997). These
channels can be characterized by dierences in their sensitivity
to apamin, which is a high anity blocker of the AHP in many
neurones. However, in some central neurones such as
hippocampal pyramidal cells, a very slow AHP (sAHP) that
is insensitive to apamin follows a train of action potentials.
When SK1-3 genes are expressed in Xenopus oocytes, the SK2
and SK3 homomeric channels are found to have a high anity
for apamin (IC50s of 60 pM and *1n M respectively) whereas
SK1 is relatively insensitive (IC504100 nM) (Kohler et al.,
1996; Vergara et al., 1998). It has been inferred from this that
SK2 and SK3 channels contribute to the apamin-sensitive
AHP currents and that SK1 channels underlie the apamin-
insensitive sAHP current.
In this study, we have examined homomeric hSK1
expressed in mammalian cell lines (human embryonic kidney
(HEK293) and monkey kidney (COS-7) cells) and report that
in these expression systems the pharmacology diers from that
reported in Xenopus oocytes. In addition to apamin, we have
also studied the eects of tubocurarine, which has been shown,
like apamin, to be less active on SK1 (IC50=350 mM) than on
SK2 channels (IC50=5.4 mM) when expressed in Xenopus
oocytes (Ishii et al., 1997). We have also tested dequalinium,
a potent blocker of the apamin-sensitive potassium channels
(Castle et al., 1993; Dunn, 1994), as well as a novel analogue of
dequalinium, UCL1848, which is a high anity blocker of the
apamin-sensitive AHP but does not aect the apamin-
insensitive sAHP in hippocampal neurones (Benton et al.,
1999).
Methods HEK293 cells and COS-7 cells were grown in
Dulbecco's Modi®ed Eagle Medium (DMEM) supplemented
with 2 mML -glutamine, 50 mgm l
71 Penicillin-Streptomycin
and 10% foetal bovine serum (HEK293 cells) or 10% new
born calf serum (COS-7 cells) (all from Life Technologies,
U.K.). For transfection purposes, the calcium phosphate
method was used. Brie¯y, a total of 6 mg of DNA was added
to 73 ml of 250 mM CaCl2. An equal volume of 26HEPES
buered saline (HBS) solution (in mM: NaCl 280, HEPES 50,
Na2HPO4 2.8, pH adjusted to 7.2 using 1M NaOH) was added
dropwise to the CaCl2 solution. After 20 min incubation at
room temperature, 75 ml of this solution was added dropwise
to a dish of cells. The cells were then incubated for 3 h at 378C.
The medium was then removed from each dish and replaced
with 15% glycerol in Hanks Balanced Salt Solution (HBSS;
Life Technologies, U.K.) and left for 1 min at room
temperature. The cells were then washed once with HBSS
before addition of the growth medium. Cells were transfected
with both hSK1 (a generous gift from Dr J.P. Adelman,
Vollum Institute, U.S.A.) and CD8 DNAs. As a matter of
routine, the pore region of hSK1 was re-sequenced using the
BigDye Terminator Cycle sequencing kit (PE Applied
Biosystems, U.K.) run on a AB1377 DNA sequencer. The
sequence was identical to that of hSK1 deposited in GenBank
(Accession no. HSU69883).
A few experiments were performed with rSK2 transfected
stably in HEK293 cells (kindly provided by Dr W. Joiner, Yale
University, U.S.A.).
Transiently transfected cells were identi®ed by adding
CD8 antibody coated microspheres (Dynabeads M-450 CD8,
Dynal, U.K.) to the cells 30 min before use (Jurman et al.,
1994). HEK293 cells were used a minimum of 24 h after
transfection whereas COS-7 cells were used at least 48 h
after transfection. Cells were superfused at 5 ml min
71 with
the following solution (in mM): NaCl 150, KCl 5, MgCl2 1, *Author for correspondence.
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(1M) NaOH. Drugs were applied by switching to bathing
¯uid containing the drug using a multiway tap. The inlet
tube was positioned such that the ¯ow was directed onto the
patched cell. Whole cell recordings from isolated cells were
made using glass micropipettes (Clark Electromedical
Instruments; GC15OTF-15) that were ®re-polished and
coated with Sylgard (Dow Corning, U.S.A.). They had
resistances of 3±5 MO when ®lled with the following
solution (in mM): KCl 130, HEDTA 5, HEPES 10, Na2ATP
2, MgCl2 3, CaCl2 0.67, pH adjusted to 7.2 using (1M)
KOH. The calcium concentration was calculated to give
1 mM free calcium using the program `REACT' (G.L. Smith,
University of Glasgow, U.K.). Cells were voltage-clamped at
780 mV using a List EPC-7 ampli®er. One hundred ms
voltage steps from 7140 mV to +40 mV in 20 mV
increments (Figure 1A) were applied every minute. Signals
were ®ltered at 10 kHz and stored on a computer using
pClamp6 (sampling frequency of 5 kHz; Axon Instruments)
for further analysis.
Data were analysed using pClamp6 software. To minimize
series resistance errors and the contribution of a signi®cant
amount of delayed recti®er current, the amplitude of the SK
current wasmeasured ata potentialof 740 mV. The amplitude
of the SK current in the presence of the drug was expressed as a
percentage of the average amplitude before and after recovery
from the drug. Results are expressed as mean+s.e.mean. The






ymax is the maximum inhibition, n is the Hill coecient and K is
the IC50 value.
AllchemicalswerepurchasedfromSigmaapartfromapamin
which was obtained from Peptides International and UCL1848
(1,1'-[1,5-pentan-diyl]-N,N'-[1,5-pentan-diyl]-bis-[4-aminoqui-
nolinium] di-tri¯uoroacetate) which was synthesized by
Professor C. R. Ganellin and colleagues at University College
London, U.K.
Results hSK1 expression in HEK293 cells Transfected cells
usually had ®ve or more CD8 antibody coated microspheres
attached to them. Transfected HEK293 cells when patched
with pipettes containing 1 mM free calcium gave currents up to
5 nA (at +40 mV), generally showing outward recti®cation at
negative potentials (Figure 1B,C). The SK1 currents ran down
initially but often stabilized within 5 min. These cells had
membrane potentials of 780 mV and the current also reversed
at approximately 780 mV (Figure 1C). The input resistance
was usually less than 100 MO. In contrast, untransfected
HEK293 cells, when patched onto with pipettes containing
1 mM free calcium as before, displayed only delayed recti®er
currents as has been previously reported (Yu & Kerchner,
1998; Figure 1A). These cells had membrane potentials
between 0 mV and 720 mV with input resistances of more
than 1 GO.
Apamin (30 nM) blocked the hSK1 current rapidly (within
2 min) in HEK293 cells (Figure 2A). The block reversed within
5 min. The IC50 value was 7.7+1.7 nM (Hill coecient of
unity, Figure 2C). However, in 15% (3/20) of the cells tested
the current was found to be only partially blocked by 30 nM
apamin (37.2+2.0%, n=3). The results from these cells were
excluded from the data presented above.
Tubocurarine and dequalinium also reduced the hSK1
current signi®cantly (Figure 2C). The IC50 values for the block
by tubocurarine and dequalinium were found to be
23.5+5.3 mM (Figure 2C) and 0.48+0.1 mM (Figure 2C)
respectively. UCL1848 was also found to potently block the
hSK1 current (IC50=1.1+0.4 nM). The concentration-re-
sponse curve produced by UCL1848, however, had a shallow
slope of 0.4+0.1 when ®tted with the Hill equation. Like
apamin, the block produced by all these compounds was rapid
with recovery occurring within 5 min of washout.
Figure 1 (A) Current recorded from untransfected HEK293 cells dialyzed with 1 mM free calcium and subjected to voltage steps
from 7140 mV to +40 mV (shown in inset). (B) Current obtained from HEK293 cells transiently transfected with hSK1 and
dialyzed with 1 mM free calcium (same voltage protocol as in A). (C) The I-V curve for the cell in B. (D and E) Represent the
currents in an untransfected COS-7 cell and a transfected COS-7 cell respectively when the cells were dialyzed with 1 mM free
calcium and the voltage protocol shown in A applied. F is the I-V curve for the current shown in E. The calibration bars shown in
A also apply to B, D and E.
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hSK1 expressed in HEK293 cells is very dierent from that in
Xenopus oocytes, we decided to express hSK1 in a second
mammalian cell line (COS-7 cells). Untransfected COS-7 cells
possess only a very small delayed recti®er type current when
patched with pipettes containing 1 mM free calcium (n=5;
Figure 1D). The membrane potential of these cells was around
0 mV and the input resistance was more than 1 GO.I n
contrast, transfected COS-7 cells had an input resistance of less
than 100 MO and membrane potentials between 770 mV and
780 mV. Currents of up to 4 nA (at +40 mV) could be
recorded (Figure 1E). These currents were generally stable,
showing little rundown. The current reversed at 780 mV
(Figure 1F), suggesting that it was carried by potassium ions.
Apamin also rapidly blocked the hSK1 current in COS-7 cells
(Figure 2B) with an IC50 value of 12.2+1.3 nM (Hill coecient
constrained to 1; Figure 2C). This IC50 value is comparable to
that observed in HEK293 cells (IC50 of 8 nM). The eect was
reversible within 5 min (Figure 2B).
rSK2 in HEK293 cells To determine whether the properties
of other SK channels also vary when expressed in mammalian
cell lines, we tested the eects of apamin on HEK293 cells
stably transfected with the rSK2 gene. In HEK293 cells
expression of rSK2 generated calcium-activated currents of up
to 5 nA (at +40 mV). As found in Xenopus oocytes, apamin is
an extremely potent blocker, with 100 pM apamin giving
71+8% (n=4) inhibition within 5 min. The eects were
reversible within 10 min of washout.
Discussion The surprising and important ®nding of this study
is that when hSK1 is transiently expressed in two dierent
mammalian cell lines, the current produced is predominantly
apamin-sensitive. These results are very dierent from those
obtained when hSK1 is expressed in Xenopus oocytes (Kohler
et al., 1996; Ishii et al., 1997). To ®nd out whether this eect
was unique to apamin, other blockers of the apamin-sensitive
channels were also tested. The hSK1 current in HEK293 cells
was moderately sensitive to tubocurarine (IC50 of 23 mM)
whereas the current obtained when hSK1 is expressed in
Xenopus oocytes is relatively insensitive (IC50 of 350 mM; Ishii
et al., 1997).
hSK1 channels in mammalian cell lines were also blocked
by dequalinium and UCL1848, which are known inhibitors of
apamin-sensitive potassium channels. UCL1848 was particu-
larly potent (Figure 2C). Interestingly, the dose-response curve
observed for this compound was shallow (Hill slope=0.4),
suggesting that binding sites with dierent anities for
UCL1848 may be present.
In contrast to our ®ndings with SK1, the pharmacology of
SK2andSK3expressedinmammaliancelllinesdoesnotseemto
dier from that in Xenopus oocytes. With rSK2, our own
®ndings give an IC50 for apamin of just below 100 pM, which is
comparabletotheIC50of60 pMinoocytes(Kohleretal.,1996).
For rSK3 expressed in HEK293 cells, the IC50 for apamin is
approximately 2 nM (Hosseini et al., 1999), close to the value of
1n Mobservedinoocytes(Vergaraetal.,1998).Therefore,ofthe
SK channels so far cloned, only the pharmacology of SK1
signi®cantly diers in dierent expression systems.
These results show that the hSK1 protein can form an
apamin-sensitive channel when expressed in mammalian cell
lines. One possible explanation is that there is a change in the
folding or assembly of the channels as, for example, occurs
with nicotinic receptors (Lewis et al., 1997). Interestingly, in
this case, a small proportion of the channels in the mammalian
cell line behaved as in oocytes whilst the properties of the
majority of the channels corresponded to the native channel
phenotype. We have also found that in 3/20 of the cells tested,
the current was only partially blocked by apamin, suggesting
that some apamin-insensitive hSK1 channels, possibly similar
to those in oocytes, may assemble in the mammalian cell lines
we have examined.
Figure 2 Examples of the block by apamin of the current produced by hSK1 transfected in HEK293 cells (A) and COS-7 cells (B).
For both examples, the trace in the presence of 30 nM apamin was obtained 2 min after bath-application of the drug. The recovery
trace was obtained 4 min after washout. (C) Concentration-inhibition curves for apamin, UCL1848, tubocurarine and dequalinium.
All the curves were ®tted using the Hill equation with ymax constrained to 100%. For the dose-response curves for apamin,
tubocurarine and dequalinium, the Hill slopes have been constrained to one. Each data point is the mean and standard error of 3±7
observations.
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additional accessory subunits expressed in either some
mammalian cell lines or Xenopus oocytes may be able to
combine with hSK1 and change the properties of the channel
that is formed. Indeed, Wadsworth et al. (1997) have puri®ed a
number of polypeptides with dierent molecular weights,
which can be photolabelled by apamin. These may represent
SK (a) subunits and possible `b subunits' alone or in
combination. The presence or absence of these additional
subunits may determine the apamin-sensitivity of hSK1.
It is worth noting that SK1 channels in these mammalian
cell lines are still less sensitive to apamin than SK2 and SK3
channels. Therefore, the amino acid residues that Ishii et al.
(1997) suggested were important for apamin sensitivity in
oocytes, are probably also important for apamin binding in
mammalian cell lines. However, these residues may also
in¯uence folding or the binding of auxiliary subunits to SK1
subunits as suggested by the result that mutated SK1 subunits
form channels that are less susceptible to rundown in oocytes
(Khawaled et al., 1999).
Because of its apamin-insensitivity and distribution in the
brain, hSK1 has been suggested to underlie the sAHP in
central neurons (Vergara et al., 1998). The present work,
however, shows that hSK1, under certain conditions, can form
apamin-sensitive channels. The identity of the channel
subunits underlying the sAHP is, therefore, still uncertain and
further work needs to be done to establish whether SK1 is
solely responsible for the apamin-insensitive sAHP or might
indeed contribute to the apamin-sensitive AHP in central
neurones.
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